Clinical Trial Update: Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease [NA]

View source ↗

Summary

A clinical trial update indicates a study examining the molecular basis of Castleman disease, Langerhans cell histiocytosis, and non-Langerhans cell histiocytos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castleman Disease
• Langerhans Cell Histiocytosis
• Non-langerhans Cell Histiocytosis

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Castleman's Disease (CD), Langerhans Cell Histiocytosis (LCH) | NA | Status: SUSPENDED